FDA Approves Oral Agent for Anemia in Dialysis: Daprodustat Is First HIF-PHI to Hit Market

Eric Seaborg
Search for other papers by Eric Seaborg in
Current site
Google Scholar
PubMed
Close
Restricted access
Save